Ibuprofen Impurity 32 - Request Quote
Ibuprofen Impurity 32
| SZ CAT No: | SZ-I002085 |
| CAS No | NA |
| Mol.F. | C13H17O2 : C11H18N |
| Mol.Wt. | 205.3 : 164.3 |
| Inv. Status | Synthesis on demand |
| Rel. CAT No | SZ-I002001 |
| Rel. CAS No | 31121-93-4 (sodium salt) ; 527688-20-6 (sodium dihydrate) ; 15687-27-1 (free base) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ibuprofen Impurity 32 is chemically (R)-3-Methyl-2-phenylbutan-1-aminium 2-(4-isobutylphenyl)propanoate. Ibuprofen Impurity 32 is supplied with detailed characterization data compliant with regulatory guideline. Ibuprofen Impurity 32 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ibuprofen.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Ibuprofen Impurity 32
Purchase Ibuprofen Impurity 32
Ibuprofen Impurity 32 suppliers
Ibuprofen Impurity 32 manufacturers
Ibuprofen Impurity 32 price
Order Ibuprofen Impurity 32
Enquire Ibuprofen Impurity 32
Ibuprofen Impurity 32 cost
Ibuprofen Impurity 32 Supplier
Ibuprofen Impurity 32 Distributor
Ibuprofen Impurity 32 for Method Validation
Ibuprofen Reference Standard
Ibuprofen Impurity 32 for ANDA Filing
Ibuprofen Impurity 32 for Forced Degradation Studies
Ibuprofen Impurity 32 Identification Standards
Ibuprofen Impurity 32 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.